Your browser doesn't support javascript.
loading
MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian, Chen; Zheng, Guoguang; Zhuang, Hongqing; Li, Xubin; Hu, Dongzhi; Zhu, Lei; Wang, Tengteng; You, Mingjian James; Zhang, Yizhuo.
Afiliação
  • Tian C; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Zheng G; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
  • Zhuang H; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Li X; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Hu D; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Zhu L; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Wang T; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • You MJ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang Y; Department of Hematology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
J Cell Physiol ; 232(6): 1387-1395, 2017 Jun.
Article em En | MEDLINE | ID: mdl-27696394
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Cell Physiol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Cell Physiol Ano de publicação: 2017 Tipo de documento: Article